Goldman Sachs Maintains Sell on Solventum, Raises Price Target to $54
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst David Roman maintains a Sell rating on Solventum (NYSE:SOLV) but raises the price target from $48 to $54.
August 12, 2024 | 3:53 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Goldman Sachs analyst David Roman maintains a Sell rating on Solventum (NYSE:SOLV) but raises the price target from $48 to $54.
The Sell rating suggests a negative outlook, but the raised price target indicates some positive expectations. The net impact is likely neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100